![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Springe zu: 2022
Anzahl der Publikationen: 1
2022
Nathan, Steven D.; Behr, Jürgen 
ORCID: https://orcid.org/0000-0002-9151-4829; Cottin, Vincent; Lancaster, Lisa; Smith, Peter; Deng, C. Q.; Pearce, Natalie ORCID: https://orcid.org/0000-0002-0545-6432; Bell, Heidi; Peterson, Leigh und Flaherty, Kevin R.
(2022):
Study design and rationale for the TETON phase 3, randomised, controlled clinical trials of inhaled treprostinil in the treatment of idiopathic pulmonary fibrosis.
In: BMJ Open Respiratory Research, Bd. 9, Nr. 1, e001310
[PDF, 498kB]
ORCID: https://orcid.org/0000-0002-9151-4829; Cottin, Vincent; Lancaster, Lisa; Smith, Peter; Deng, C. Q.; Pearce, Natalie ORCID: https://orcid.org/0000-0002-0545-6432; Bell, Heidi; Peterson, Leigh und Flaherty, Kevin R.
(2022):
Study design and rationale for the TETON phase 3, randomised, controlled clinical trials of inhaled treprostinil in the treatment of idiopathic pulmonary fibrosis.
In: BMJ Open Respiratory Research, Bd. 9, Nr. 1, e001310
[PDF, 498kB]